Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX: AXPH)

AXPH Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Net Income	210.1	126.43	117.42	117	170.05	112.85
Depreciation & Amortization	55.3	28	23.18	-	-	-
Other Operating Activities	-103.23	-63.09	52.14	-17.57	-30.25	24.96
Operating Cash Flow	162.17	91.34	192.75	99.42	139.8	137.81
Operating Cash Flow Growth	20.13%	-52.61%	93.87%	-28.88%	1.44%	70.14%
Capital Expenditures	-76.53	-84.25	-31.85	-119.99	-71.22	-13.1
Sale of Property, Plant & Equipment	0.75	1.03	-	0.4	-	-
Other Investing Activities	9.93	5.38	5.25	5.97	11.21	13.29
Investing Cash Flow	-65.85	-77.84	-26.6	-113.62	-60.02	0.2
Common Dividends Paid	-79.58	-76.94	-64.52	-100.29	-78.08	-64.94
Financing Cash Flow	-79.58	-76.94	-64.52	-100.29	-78.08	-64.94
Net Cash Flow	16.74	-63.44	101.63	-114.49	1.7	73.07
Free Cash Flow	85.64	7.09	160.9	-20.57	68.57	124.72
Free Cash Flow Growth	13.34%	-95.59%	-	-	-45.02%	150.30%
Free Cash Flow Margin	4.75%	0.48%	14.63%	-1.86%	6.69%	15.04%
Free Cash Flow Per Share	17.13	1.42	32.18	-4.11	11.61	19.94
Cash Income Tax Paid	41.24	46.02	49.3	62.87	44.24	50.82
Levered Free Cash Flow	-	-16.18	155.37	-46.87	20.89	110.7
Unlevered Free Cash Flow	-	-16.18	155.37	-46.87	20.89	110.7
Change in Net Working Capital	-	56.76	-79.95	23.2	46.45	-32.68

Source: S&P Capital IQ. Standard template. Financial Sources.